Hepatitis B Vaccines Market
1 Study Coverage
1.1 Hepatitis B Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccines Sales by Region
2.4.1 Global Hepatitis B Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccines by Region (2023-2028)
2.5 Global Hepatitis B Vaccines Revenue by Region
2.5.1 Global Hepatitis B Vaccines Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccines Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccines in 2021
3.2 Global Hepatitis B Vaccines Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2021
3.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccines Sales by Type
4.1.1 Global Hepatitis B Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccines Revenue by Type
4.2.1 Global Hepatitis B Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccines Price by Type
4.3.1 Global Hepatitis B Vaccines Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccines Sales by Application
5.1.1 Global Hepatitis B Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccines Revenue by Application
5.2.1 Global Hepatitis B Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccines Price by Application
5.3.1 Global Hepatitis B Vaccines Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccines Market Size by Type
6.1.1 North America Hepatitis B Vaccines Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccines Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccines Market Size by Application
6.2.1 North America Hepatitis B Vaccines Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccines Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccines Market Size by Country
6.3.1 North America Hepatitis B Vaccines Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccines Market Size by Type
7.1.1 Europe Hepatitis B Vaccines Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccines Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccines Market Size by Application
7.2.1 Europe Hepatitis B Vaccines Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccines Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccines Market Size by Country
7.3.1 Europe Hepatitis B Vaccines Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccines Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccines Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccines Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis B Vaccines Market Size by Type
9.1.1 Latin America Hepatitis B Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccines Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccines Market Size by Application
9.2.1 Latin America Hepatitis B Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccines Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccines Market Size by Country
9.3.1 Latin America Hepatitis B Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccines Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccines Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccines Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 NCPC
11.2.1 NCPC Corporation Information
11.2.2 NCPC Overview
11.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NCPC Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Bio Kangtai
11.4.1 Bio Kangtai Corporation Information
11.4.2 Bio Kangtai Overview
11.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Kangtai Recent Developments
11.5 Dynavax
11.5.1 Dynavax Corporation Information
11.5.2 Dynavax Overview
11.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dynavax Recent Developments
11.6 Hissen
11.6.1 Hissen Corporation Information
11.6.2 Hissen Overview
11.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hissen Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 LG Life Sciences
11.8.1 LG Life Sciences Corporation Information
11.8.2 LG Life Sciences Overview
11.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LG Life Sciences Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Corporation Information
11.9.2 Serum Institute Overview
11.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccines Industry Chain Analysis
12.2 Hepatitis B Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccines Production Mode & Process
12.4 Hepatitis B Vaccines Sales and Marketing
12.4.1 Hepatitis B Vaccines Sales Channels
12.4.2 Hepatitis B Vaccines Distributors
12.5 Hepatitis B Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccines Industry Trends
13.2 Hepatitis B Vaccines Market Drivers
13.3 Hepatitis B Vaccines Market Challenges
13.4 Hepatitis B Vaccines Market Restraints
14 Key Findings in The Global Hepatitis B Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Yeast Derived
Table 3. Major Manufacturers of CHO Derived
Table 4. Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Hepatitis B Vaccines Sales by Region (2017-2022) & (M Doses)
Table 7. Global Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Hepatitis B Vaccines Sales by Region (2023-2028) & (M Doses)
Table 9. Global Hepatitis B Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Hepatitis B Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Hepatitis B Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Hepatitis B Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Hepatitis B Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Hepatitis B Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Hepatitis B Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Hepatitis B Vaccines Price by Manufacturers (2017-2022) &(USD/Doses)
Table 19. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2021)
Table 21. Hepatitis B Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis B Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Hepatitis B Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 26. Global Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 27. Global Hepatitis B Vaccines Sales Share by Type (2017-2022)
Table 28. Global Hepatitis B Vaccines Sales Share by Type (2023-2028)
Table 29. Global Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Hepatitis B Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Hepatitis B Vaccines Revenue Share by Type (2023-2028)
Table 33. Hepatitis B Vaccines Price by Type (2017-2022) & (USD/Doses)
Table 34. Global Hepatitis B Vaccines Price Forecast by Type (2023-2028) & (USD/Doses)
Table 35. Global Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 36. Global Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 37. Global Hepatitis B Vaccines Sales Share by Application (2017-2022)
Table 38. Global Hepatitis B Vaccines Sales Share by Application (2023-2028)
Table 39. Global Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Hepatitis B Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Hepatitis B Vaccines Revenue Share by Application (2023-2028)
Table 43. Hepatitis B Vaccines Price by Application (2017-2022) & (USD/Doses)
Table 44. Global Hepatitis B Vaccines Price Forecast by Application (2023-2028) & (USD/Doses)
Table 45. North America Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. North America Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 47. North America Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 50. North America Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 51. North America Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 54. North America Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
Table 55. North America Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Hepatitis B Vaccines Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Hepatitis B Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. GSK Corporation Information
Table 106. GSK Description and Major Businesses
Table 107. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 108. GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GSK Recent Developments
Table 110. NCPC Corporation Information
Table 111. NCPC Description and Major Businesses
Table 112. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 113. NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. NCPC Recent Developments
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 118. Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck Recent Developments
Table 120. Bio Kangtai Corporation Information
Table 121. Bio Kangtai Description and Major Businesses
Table 122. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 123. Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bio Kangtai Recent Developments
Table 125. Dynavax Corporation Information
Table 126. Dynavax Description and Major Businesses
Table 127. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 128. Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Dynavax Recent Developments
Table 130. Hissen Corporation Information
Table 131. Hissen Description and Major Businesses
Table 132. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 133. Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Hissen Recent Developments
Table 135. KM Biologics Corporation Information
Table 136. KM Biologics Description and Major Businesses
Table 137. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 138. KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. KM Biologics Recent Developments
Table 140. LG Life Sciences Corporation Information
Table 141. LG Life Sciences Description and Major Businesses
Table 142. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 143. LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. LG Life Sciences Recent Developments
Table 145. Serum Institute Corporation Information
Table 146. Serum Institute Description and Major Businesses
Table 147. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 148. Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Serum Institute Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Hepatitis B Vaccines Distributors List
Table 153. Hepatitis B Vaccines Customers List
Table 154. Hepatitis B Vaccines Market Trends
Table 155. Hepatitis B Vaccines Market Drivers
Table 156. Hepatitis B Vaccines Market Challenges
Table 157. Hepatitis B Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 3. Global Hepatitis B Vaccines Market Share by Type in 2021 & 2028
Figure 3. Yeast Derived Product Picture
Figure 4. CHO Derived Product Picture
Figure 5. Global Hepatitis B Vaccines Market Share by Application in 2021 & 2028
Figure 6. Children
Figure 7. Adult
Figure 8. Hepatitis B Vaccines Report Years Considered
Figure 9. Global Hepatitis B Vaccines Sales 2017-2028 (M Doses)
Figure 10. Global Hepatitis B Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Hepatitis B Vaccines Revenue 2017-2028 (US$ Million)
Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
Figure 14. Global Hepatitis B Vaccines Sales Market Share by Region (2023-2028)
Figure 15. North America Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 16. North America Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 18. Europe Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 20. Asia-Pacific Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 22. Latin America Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 24. Middle East & Africa Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Hepatitis B Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Hepatitis B Vaccines in the World: Market Share by Hepatitis B Vaccines Revenue in 2021
Figure 27. Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 29. Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 30. Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 31. Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 32. North America Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. North America Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 35. North America Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. North America Hepatitis B Vaccines Sales Share by Country (2017-2028)
Figure 37. North America Hepatitis B Vaccines Revenue Share by Country (2017-2028)
Figure 38. U.S. Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 41. Europe Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 42. Europe Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 43. Europe Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 44. Europe Hepatitis B Vaccines Sales Share by Country (2017-2028)
Figure 45. Europe Hepatitis B Vaccines Revenue Share by Country (2017-2028)
Figure 46. Germany Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 47. France Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Hepatitis B Vaccines Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Hepatitis B Vaccines Revenue Share by Region (2017-2028)
Figure 57. China Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. India Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Latin America Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Latin America Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Hepatitis B Vaccines Sales Share by Country (2017-2028)
Figure 72. Latin America Hepatitis B Vaccines Revenue Share by Country (2017-2028)
Figure 73. Mexico Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Hepatitis B Vaccines Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Hepatitis B Vaccines Revenue Share by Country (2017-2028)
Figure 82. Turkey Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Hepatitis B Vaccines Value Chain
Figure 86. Hepatitis B Vaccines Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Industry Market Size
